Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731087) titled 'MSC Secretome Therapy for Cognitive Recovery After Subacute Ischemic Stroke' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Jumraini Tammasse
Condition:
Ischemic Stroke
Post-Stroke Cognitive Impairment
Intervention:
Biological: Umbilical Cord Mesenchymal Stem Cell-Derived Secretome
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: July 9, 2026
Target Sample Size: 70
Countries of Recruitment:
Indonesia
To know more, visit https://clini...